FDA Approves Merck’s Pimjetmi for Tenosynovial Giant Cell Tumor
The FDA approved Merck KGaA’s PIMJET for tenosynovial giant cell tumor.
Related stories
US Commerce Department Delays Megaspeed’s Trade Blacklist Inclusion
The Commerce Department delayed Megaspeed’s inclusion on a trade blacklist, according to the headline.
L impact | REGULATION | Nov 10, 2026, 08:11 PM UTC
US Delays Megaspeed’s Addition to Trade Blacklist
The US Commerce Department delayed Megaspeed’s inclusion on a trade blacklist, the Financial Times reported.
M impact | REGULATION | Nov 10, 2026, 08:08 PM UTC
US delays Megaspeed’s inclusion on trade blacklist
The US Commerce Department delays Megaspeed’s inclusion on a trade blacklist, according to the Financial Times.
M impact | REGULATION | Nov 10, 2026, 08:08 PM UTC
US Regulator Postpones Wall Street Push To Trade AI Computing Futures — FT
L impact | REGULATION | Nov 10, 2026, 08:00 PM UTC
Today's biggest % gainers/losers
The following are today's top 20 percentage gainers and top 20 percentage losers, categorized by sec
L impact | REGULATION | Nov 10, 2026, 07:20 PM UTC
SEC May Scale Back Executive Pay Disclosure Requirements
02:11 PM EST, 11/10/2026 (MT Newswires) -- The Securities and Exchange Commission is expected to rel
L impact | REGULATION | Nov 10, 2026, 07:11 PM UTC